| Product NDC: | 57955-5045 | 
| Proprietary Name: | Bladder Incontinence | 
| Non Proprietary Name: | Belladonna, Bellis perennis, Benzoicum acidum, Causticum, Equisetum hyemale, Lycopodium clavatum, Phosphorus, Plantago major, Rhus aromatica, Sepia | 
| Active Ingredient(s): | 10; 10; 10; 10; 10; 10; 10; 10; 10; 10 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL & nbsp; Belladonna, Bellis perennis, Benzoicum acidum, Causticum, Equisetum hyemale, Lycopodium clavatum, Phosphorus, Plantago major, Rhus aromatica, Sepia | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | LIQUID | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 57955-5045 | 
| Labeler Name: | King Bio Inc. | 
| Product Type: | HUMAN OTC DRUG | 
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC | 
| Start Marketing Date: | 20120313 | 
| Package NDC: | 57955-5045-2 | 
| Package Description: | 59 mL in 1 BOTTLE, SPRAY (57955-5045-2) | 
| NDC Code | 57955-5045-2 | 
| Proprietary Name | Bladder Incontinence | 
| Package Description | 59 mL in 1 BOTTLE, SPRAY (57955-5045-2) | 
| Product NDC | 57955-5045 | 
| Product Type Name | HUMAN OTC DRUG | 
| Non Proprietary Name | Belladonna, Bellis perennis, Benzoicum acidum, Causticum, Equisetum hyemale, Lycopodium clavatum, Phosphorus, Plantago major, Rhus aromatica, Sepia | 
| Dosage Form Name | LIQUID | 
| Route Name | ORAL | 
| Start Marketing Date | 20120313 | 
| Marketing Category Name | UNAPPROVED HOMEOPATHIC | 
| Labeler Name | King Bio Inc. | 
| Substance Name | ATROPA BELLADONNA; BELLIS PERENNIS; BENZOIC ACID; CAUSTICUM; EQUISETUM HYEMALE; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; PLANTAGO MAJOR; RHUS AROMATICA ROOT BARK; SEPIA OFFICINALIS JUICE | 
| Strength Number | 10; 10; 10; 10; 10; 10; 10; 10; 10; 10 | 
| Strength Unit | [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL | 
| Pharmaceutical Classes |